American Century Companies’s RAPT Therapeutics RAPT Stock Holding History

American Century Companies’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,218	Closed	-$346K	–	2906
2025 Q4	$346K	Buy	+10,218	New	+$317K	﹤0.01%	2605

American Century Companies's RAPT Position: Q1 2026 in Review

American Century Companies sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 10,218 shares — an estimated $346K sold.

American Century Companies first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $346K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

American Century Companies reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
American Century Companies sold 10,218 RAPT Therapeutics shares in Q1 2026, an estimated $346K.
American Century Companies first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
American Century Companies's RAPT Therapeutics position peaked at $346K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.